Ketamine as a prophylactic resilience-enhancing agent.

Evers, Audrey G; Murrough, James W; Charney, Dennis S; Costi, Sara

Evers, Audrey G; Murrough, James W; Charney, Dennis S; Costi, Sara.

Afiliação

Evers AG; Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Murrough JW; Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Charney DS; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Costi S; Depression and Anxiety Center for Discovery and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Front Psychiatry ; 13: 833259, 2022.

Article em En | MEDLINE | ID: mdl-35966469

Palavras-chave

ketamine; prevention; prophylactic; resilience; stress

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google